Zoledronic acid 4 mg/5mL (Zoledronic acid INJECTION, SOLUTION, CONCENTRATE) 4 mg/5mL

Zoledronic acid 4 mg/5mL is an intravenous solution used for bone health and osteoporosis management. This concentrate is designed for dilution before administration.

Strength

4 mg/5mL

Pack Size

1 VIAL, GLASS in 1 CARTON (23155-170-31) / 5 mL in 1 VIAL, GLASS

Manufacturer / TM Owner

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zoledronic acid is primarily used to treat conditions related to bone health, such as osteoporosis and bone metastases. It is often prescribed to improve bone density and reduce the risk of fractures. Patients may wonder, 'What is Zoledronic acid used for?' It is commonly utilized in the management of Paget's disease of bone and to prevent skeletal complications in certain cancers.

Side Effects

Common effects of Zoledronic acid may include flu-like symptoms, fever, and muscle pain. Some individuals might experience fatigue or mild gastrointestinal discomfort. These effects are generally temporary and vary among users.

Precautions & Warnings

Zoledronic acid should be handled with care, as it is a potent medication. It is essential to follow healthcare provider instructions for dilution and administration. Patients with kidney issues should discuss their condition with a healthcare professional before use.

Avoid Interactions

Zoledronic acid may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other bone-related treatments. It is important to inform healthcare providers about all current medications to avoid potential interactions.

Frequently Asked Questions

Zoledronic acid is used to treat conditions related to bone health, such as osteoporosis and bone metastases.

Zoledronic acid is administered intravenously after dilution, typically in a clinical setting.

Common side effects may include flu-like symptoms, fever, muscle pain, fatigue, and mild gastrointestinal discomfort.

Zoledronic acid may interact with certain medications, so it is important to consult a healthcare provider before combining treatments.

Patients with kidney issues should discuss their condition with a healthcare professional before using Zoledronic acid.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.